Clinical Trials Browser

Phase 1/2 × Advan'ce'd × Bevacizumab × Clear all

NCT07361991 2026-01-23

IBI363 Plus Bevacizumab With or Without Nab-Paclitaxel for Second-Line Treatment of Advanced Gastric Cancer

Phase 1/2 Not yet recruiting

Advan'ce'd